A 24-Week, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Evaluation of the Efficacy, Safety and Tolerability of Donepezil Hydrochloride (E2020) in Patients With Dementia Associated With Cerebrovascular Disease.
Phase of Trial: Phase III
Latest Information Update: 31 Mar 2011
At a glance
- Drugs Donepezil (Primary)
- Indications Vascular dementia
- Focus Adverse reactions; Therapeutic Use
- 15 Apr 2010 Results published in Stroke.
- 14 Nov 2005 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History